A metal-organic framework-based immunomodulatory nanoplatform for anti-atherosclerosis treatment

Regulation of the macrophage-related inflammatory microenvironment for atherosclerosis treatment and angiogenesis via anti-cytokine agents

(2022) Hongji Pu et al.   Nano Research

A multimodal Metal-Organic framework based on unsaturated metal site for enhancing antitumor cytotoxicity through Chemo-Photodynamic therapy

(2022) Qiongjie Ding et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

Virtual Transcriptomics

(2021) Andrew J. Buckler et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The changing landscape of atherosclerosis

(2021) Peter Libby   NATURE

Targeting inflammation in atherosclerosis — from experimental insights to the clinic

(2021) Oliver Soehnlein et al.   NATURE REVIEWS DRUG DISCOVERY

Multivariate Modulation of the Zr MOF UiO-66 for Defect-Controlled Combination Anticancer Drug Delivery

(2020) Isabel Abánades Lázaro et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges

(2020) John D. Martin et al.   Nature Reviews Clinical Oncology

Metal–Organic Frameworks for Biomedical Applications

(2020) Jie Yang et al.   Small

Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages

(2020) Dong Wang et al.   CANCER LETTERS

Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines

(2020) Cheng Gao et al.   Nature Communications

A multifunctional aminated UiO-67 metal-organic framework for enhancing antitumor cytotoxicity through bimodal drug delivery

(2020) Weicong Liu et al.   CHEMICAL ENGINEERING JOURNAL

Immunity and Inflammation in Atherosclerosis

(2019) Dennis Wolf et al.   CIRCULATION RESEARCH

Delivery technologies for cancer immunotherapy

(2019) Rachel S. Riley et al.   NATURE REVIEWS DRUG DISCOVERY

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

(2019) Elizabeth I. Buchbinder et al.   Journal for ImmunoTherapy of Cancer

Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

(2019) Emelia J. Benjamin et al.   CIRCULATION

Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis

(2019) Ying Wang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Immunotherapy for cardiovascular disease

(2019) Esther Lutgens et al.   EUROPEAN HEART JOURNAL

The role of Interleukin 1 receptor antagonist in mesenchymal stem cell‐based tissue repair and regeneration

(2019) Carl Randall Harrell et al.   BIOFACTORS

Rapamycin-Loaded Leukosomes Reverse Vascular Inflammation

(2019) Christian Boada et al.   CIRCULATION RESEARCH

Macrophage polarization in atherosclerosis

(2019) Sai Yang et al.   CLINICA CHIMICA ACTA

An acute immune response underlies the benefit of cardiac stem-cell therapy

(2019) Ronald J. Vagnozzi et al.   NATURE

Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis

(2018) Kathryn J. Moore et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Seasonal variations in cardiovascular disease

(2017) Simon Stewart et al.   Nature Reviews Cardiology

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFκB pathways in autophagy- and p62-dependent manners

(2017) Jung Hwa Ko et al.   Oncotarget

Nanomaterials derived from metal–organic frameworks

(2017) Song Dang et al.   Nature Reviews Materials

Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis

(2016) D. Karunakaran et al.   Science Advances

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

(2015) Rebecca C Coll et al.   NATURE MEDICINE

Mesenchymal Stem Cell-Derived Interleukin 1 Receptor Antagonist Promotes Macrophage Polarization and Inhibits B Cell Differentiation

(2015) Patricia Luz-Crawford et al.   STEM CELLS

Rapamycin: One Drug, Many Effects

(2014) Jing Li et al.   Cell Metabolism

Interleukin-10 Receptor Signaling in Innate Immune Cells Regulates Mucosal Immune Tolerance and Anti-Inflammatory Macrophage Function

(2014) Dror S. Shouval et al.   IMMUNITY

Molecular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer Progression

(2014) Manesh Chittezhath et al.   IMMUNITY

Macrophage phenotypes in atherosclerosis

(2014) Sophie Colin et al.   IMMUNOLOGICAL REVIEWS

A facile synthesis of UiO-66, UiO-67 and their derivatives

(2013) Michael J. Katz et al.   CHEMICAL COMMUNICATIONS

Rapamycin unbalances the polarization of human macrophages to M1

(2013) Alessia Mercalli et al.   IMMUNOLOGY

mTOR is a key modulator of ageing and age-related disease

(2013) Simon C. Johnson et al.   NATURE

Modulation of macrophage phenotype by cell shape

(2013) F. Y. McWhorter et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy

(2012) Jason Park et al.   NATURE MATERIALS

Macrophages in the Pathogenesis of Atherosclerosis

(2011) Kathryn J. Moore et al.   CELL

IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets

(2009) Sven Létourneau et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY